Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 10987 | 2021 |
XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease A Kaser, AH Lee, A Franke, JN Glickman, S Zeissig, H Tilg, ... Cell 134 (5), 743-756, 2008 | 1656 | 2008 |
Visfatin, an adipocytokine with proinflammatory and immunomodulating properties AR Moschen, A Kaser, B Enrich, B Mosheimer, M Theurl, H Niederegger, ... The Journal of Immunology 178 (3), 1748-1758, 2007 | 1395 | 2007 |
Gut microbiome, obesity, and metabolic dysfunction H Tilg, A Kaser The Journal of clinical investigation 121 (6), 2126-2132, 2011 | 1103 | 2011 |
Crohn’s disease G Roda, S Chien Ng, PG Kotze, M Argollo, R Panaccione, A Spinelli, ... Nature Reviews Disease Primers 6 (1), 22, 2020 | 939 | 2020 |
Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis A Kaser, G Brandacher, W Steurer, S Kaser, FA Offner, H Zoller, I Theurl, ... Blood, The Journal of the American Society of Hematology 98 (9), 2720-2725, 2001 | 817 | 2001 |
Paneth cells as a site of origin for intestinal inflammation TE Adolph, MF Tomczak, L Niederreiter, HJ Ko, J Böck, E Martinez-Naves, ... Nature 503 (7475), 272-276, 2013 | 810 | 2013 |
The unfolded protein response in immunity and inflammation J Grootjans, A Kaser, RJ Kaufman, RS Blumberg Nature Reviews Immunology 16 (8), 469-484, 2016 | 800 | 2016 |
Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro S Kaser, A Kaser, A Sandhofer, CF Ebenbichler, H Tilg, JR Patsch Biochemical and biophysical research communications 309 (2), 286-290, 2003 | 734 | 2003 |
European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease JF Rahier, S Ben-Horin, Y Chowers, C Conlon, P De Munter, G D'Haens, ... Journal of Crohn's and Colitis 3 (2), 47-91, 2009 | 707 | 2009 |
Adiponectin and its receptors in non-alcoholic steatohepatitis S Kaser, A Moschen, A Cayon, A Kaser, J Crespo, F Pons-Romero, ... Gut 54 (1), 117-121, 2005 | 607 | 2005 |
Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice P Fickert, A Fuchsbichler, M Wagner, G Zollner, A Kaser, H Tilg, R Krause, ... Gastroenterology 127 (1), 261-274, 2004 | 580 | 2004 |
Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled … BG Feagan, WJ Sandborn, G D'Haens, J Panés, A Kaser, M Ferrante, ... The Lancet 389 (10080), 1699-1709, 2017 | 483 | 2017 |
Genome-wide association analysis in primary sclerosing cholangitis TH Karlsen, A Franke, E Melum, A Kaser, JR Hov, T Balschun, BA Lie, ... Gastroenterology 138 (3), 1102-1111, 2010 | 419 | 2010 |
Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation MZ Cader, A Kaser Gut 62 (11), 1653-1664, 2013 | 407 | 2013 |
Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation F Sampaziotis, M Cardoso de Brito, P Madrigal, A Bertero, K Saeb-Parsy, ... Nature biotechnology 33 (8), 845-852, 2015 | 403 | 2015 |
Gut, inflammation and osteoporosis: basic and clinical concepts H Tilg, AR Moschen, A Kaser, A Pines, I Dotan Gut 57 (5), 684-694, 2008 | 381 | 2008 |
Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis H Tilg, R Jalan, A Kaser, NA Davies, FA Offner, SJ Hodges, O Ludwiczek, ... Journal of hepatology 38 (4), 419-425, 2003 | 351 | 2003 |
Lipocalin 2 protects from inflammation and tumorigenesis associated with gut microbiota alterations AR Moschen, RR Gerner, J Wang, V Klepsch, TE Adolph, SJ Reider, ... Cell host & microbe 19 (4), 455-469, 2016 | 331 | 2016 |
Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon γ H Tilg, C Van Montfrans, A Van den Ende, A Kaser, SJH Van Deventer, ... Gut 50 (2), 191-195, 2002 | 321 | 2002 |